FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Diabetes patients Dr. Kamal Kant Kohli24 Dec 2024 8:15 PM ISTThe U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a...
Biocon, Zentiva gets Decentralized Procedure approval for generic diabetes, weight management drug in EU Ruchika Sharma24 Dec 2024 11:36 AM ISTBangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex...
No casual link found between GLP-1 drugs like Novo Nordisk Ozempic, thyroid cancer: EMA Ruchika Sharma29 Oct 2023 12:30 PM ISTThe European Medicines Agency (EMA) has said its safety panel did not find a causal link between popular GLP-1 drugs such as Novo...
Weight loss: Liraglutide 3.0 mg plus Intensive behavioral therapy show positive results, says SCALE IBT Randomized Controlled Trial Dr. Kamal Kant Kohli24 Feb 2020 4:59 PM ISTThe study is the first multi-site evaluation of the efficacy of IBT based on a treatment visit schedule covered by the Centers for Medicare and...
Novo Nordisk says Victoza helps lower heart risks savita thakur thakur6 March 2016 12:15 PM ISTCopenhagen: Novo Nordisk said on Friday the results from a trial showed that its Victoza diabetes drug significantly reduced the risks of major...
Novo Nordisk diabetes drug fails to help heart failure -study Pooja Bhatia Bhatia9 Nov 2015 9:30 AM ISTOrlando :The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure,...
